Entering text into the input field will update the search result below

Relay set to Equal Weight at Barclays; says fairly valued ahead of catalysts

Sep. 30, 2022 10:25 AM ETRelay Therapeutics, Inc. (RLAY) StockBy: Dulan Lokuwithana, SA News Editor1 Comment

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

  • Barclays has launched its coverage on Relay Therapeutics, Inc. (NASDAQ:RLAY) with an Equal Weight rating and a $23 price target, noting that the Cambridge, Massachusetts-based biotech remains fairly valued despite upcoming catalysts.
  • The analyst Peter

Recommended For You

About RLAY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RLAY--
Relay Therapeutics, Inc.